MDCE CEO Expands Open-Market Position to 66,199,283 Shares After Previously Returning Nearly 2 Billion Shares to Treasury

Rhea-AI Summary

Medical Care Technologies (OTC Pink: MDCE) said CEO Marshall Perkins bought 16,199,283 shares on the open market at $0.0002 per share, bringing his total holdings to 66,199,283 shares as of February 20, 2026.

The company confirmed no new shares were issued and outstanding shares remain 3,392,275,230 after Mr. Perkins earlier returned nearly 2 billion matured shares to treasury to avoid an approximate 66% increase in outstanding count.

Positive

• CEO open-market buy of 16,199,283 shares at $0.0002
• CEO ownership now 66,199,283 shares indicating insider alignment
• Outstanding shares preserved at 3,392,275,230 after treasury return

Negative

• Previously matured shares totaling ~2 billion were at risk of increasing outstanding shares by ~66%
• High outstanding share count of 3.39 billion may limit short-term per-share upside

Continued CEO Investment Signals Alignment with Shareholders and Confidence in Long-Term Corporate Strategy

MESA, ARIZONA / ACCESS Newswire / February 20, 2026 / Medical Care Technologies Inc. (OTC Pink:MDCE) (the "Company") today announced that its Chief Executive Officer, Marshall Perkins, purchased 16,199,283 shares of MDCE common stock on the open market at a purchase price of $0.0002 per share in a series of transactions last week.

The shares were acquired using Mr. Perkins' personal funds and represent a direct open-market investment. No new shares were issued by the Company in connection with this transaction, and the purchase does not constitute a corporate action.

As of the date of this release, the Company's outstanding share count remains unchanged at 3,392,275,230 shares of common stock.

Following this most recent transaction, Mr. Perkins now owns a total of 66,199,283 shares of MDCE common stock, all of which have been purchased on the open market using personal funds. Mr. Perkins has indicated that he intends to continue accumulating shares in the open market in the coming quarters, subject to market conditions and applicable regulations.

Previously, Mr. Perkins voluntarily returned nearly 2 billion shares to treasury that had matured and were eligible for sale. That action was undertaken to combat the effects of funding-related dilution and to prevent the outstanding share count from increasing by approximately 66%. As a result, the Company's outstanding shares were preserved at current levels rather than materially expanding.

"Over the past year, I have taken deliberate steps to protect shareholder structure," said Marshall Perkins, Chief Executive Officer. "Returning nearly two billion matured shares to treasury was a decision made to prevent a dramatic change to the outstanding share count. Today, I am continuing to invest personal capital directly into the open market. My focus remains on disciplined execution, transparency, and building long-term value across our AI lifestyle and medical technology initiatives."

The Company continues advancing its artificial intelligence portfolio, including consumer-facing applications within its lifestyle division and medical pre-screening technologies currently under development. Management remains committed to responsible capital structure management and transparent communication with shareholders.

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (OTC Pink:MDCE) is a development-stage technology company focused on integrating artificial intelligence into consumer-facing lifestyle applications and medical pre-screening platforms. The Company operates under the Alternative Reporting Standard and provides regular updates through its OTC Markets profile at www.otcmarkets.com/stock/MDCE.

For more information, please visit www.medicalcaretechnologies.com.

Contact Information

Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221
Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: info@infiniteauctions.com
Website: www.mdcestock.com

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Factors that could cause such differences include general economic conditions, changes in market demand, competitive factors, regulatory developments, and other risks detailed in the Company's public disclosures. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law.

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

How many MDCE shares did CEO Marshall Perkins buy on February 20, 2026?

He bought 16,199,283 MDCE shares on the open market at $0.0002 per share. According to the company, purchases used his personal funds and did not involve new company-issued shares.

What is Marshall Perkins' total MDCE share ownership after the February 20, 2026 purchase?

Marshall Perkins now owns 66,199,283 MDCE shares in total. According to the company, all shares were acquired on the open market using his personal funds.

Did MDCE issue new shares for the CEO purchase announced February 20, 2026?

No, the company said no new shares were issued in connection with the transaction. According to the company, the purchase was a personal open-market investment by the CEO.

How many MDCE shares remain outstanding after the treasury return and CEO buyback?

Outstanding shares remain 3,392,275,230 according to the company. Management says returning nearly 2 billion matured shares prevented an approximate 66% rise in outstanding count.

What was the purpose of returning nearly 2 billion MDCE shares to treasury?

The return aimed to prevent funding-related dilution and stop an approximate 66% increase in outstanding shares. According to the company, this preserved the existing shareholder structure.

Will Marshall Perkins buy more MDCE shares after February 20, 2026?

He indicated an intention to continue accumulating shares in coming quarters, subject to market conditions and regulations. According to the company, further purchases would be open-market and personal investments.